Thomas C. Reynolds, Chief Medical Officer at SEATTLE GENETICS INC /WA (SGEN), sold 25,000 shares at $16.95 ($424K) on 2010-10-11, disclosed to the SEC on 2010-10-12.
Scheduled sale ($424k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| SGEN | SELL | 2013-01-17 | $3.5M | — | Filing → |
| SGEN | SELL | 2012-12-10 | $1.7M | — | Filing → |
| SGEN | SELL | 2012-12-06 | $1.0M | — | Filing → |